Gilead Sciences GILD
NASDAQ GILD
$152.21 +1.28 (+0.85%)
At close: Sep 28, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Land & Improvements (2010 - 2011)

Updated

Gilead Sciences (GILD) posted Land & Improvements of $149.38 million for Q4 2011, up 8.4% from $137.81 million a year earlier.

Analysis

Gilead Sciences (GILD) Land & Improvements (2010 - 2011) Analysis & Trends

  • In prior years, Gilead Sciences' Land & Improvements was $137.81 million in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 157.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 149.38 Mn
Dec 31, 2010 137.81 Mn
API Access

Gilead Sciences Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=GILD&period=max&api_key=YOUR_API_KEY